ClinicalTrials.gov
public full text
Public Domain
Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones
The purpose of this study is to determine the efficacy of febuxostat, once daily (QD), compared to allopurinol or placebo in patients with excessive amounts of uric acid in their urine and who have recently had kidney stones.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Gut Oxalate Absorption in Calcium Oxalate Stone Disease#1137560
- Comparing Patients After ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin#982099
- Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.#890224
- Comparison of Different Methods for Measuring Urinary Oxalate and Citrate: An Observational Study#897640
- Paxerol™ for Treatment of Nocturia - A Phase II Placebo-Controlled Trial#894730
Record · ID 894510
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive